Icon buys PRA Health Sciences in $12bn deal Irish contract research firm Icon is to buy rival PRA Health Sciences in a deal valued at about $12bn, expanding into virtual clinical trials that … Business • 24 Feb 21
ICON acquires health outcomes research firm Mapi Group Clinical research firm ICON has announced the acquisition of Mapi Group, a health outcomes research and commercialisation company with around 750 employees in 12 countries. Business • 27 Jul 17
ICON sees 7.8% net revenue rise in Q1 The Dublin-headquartered drug development solutions provider ICON reported a 7.8% rise in net revenue for the first three months of the year to $432m. Business • 27 Apr 17
ICON names Cutler as new CEO Clinical research firm ICON has reported third quarter net revenue of $420.2m, an increase of 6.4% from the $394.7m reported the same time last year. Business • 20 Oct 16
ICON records record net new business during Q2 Dublin-based Drug development firm ICON recorded record net new business of over $500m (€454m) during the second quarter. Business • 26 Jul 16
Icon sees strong income growth in first quarter Clinical research firm Icon has reported a jump in income during the first quarter, as revenue rose despite the impact of adverse currency movements. Business • 26 Apr 16
ICON's third quarter revenues move 1.8% higher Pharma company ICON has reported net revenues of $394.7m for the third quarter to the end of September, up 1.8% on the $387.5m the same … Business • 27 Oct 15
Icon records 54.7% rise in pre-tax profit for Q1 Dublin-based firm Icon has reported a 54.7% rise in pre-tax profit in the first quarter of 2015 after a sharp rise in company revenue. Business • 28 Apr 15
ICON pledges 200 jobs as 2015 Action Plan launched Irish multinational company ICON is to create 200 jobs in a new Global Innovation Hub. The announcement was made as the Government launched the Action … News • 30 Jan 15
Icon pays $52 for US firm Icon, a Dublin-based company which conducts clinical trials for the pharmaceutical and medical devices industries, has acquired US-based healthcare company in a deal valued at … Business • 04 Feb 13
ICON fined €10,000 by Central Bank The Central Bank has fined ICON PLC €10,000 in relation to breaches of the Market Abuse Rules. Business • 22 Nov 12
ICON to withdraw from ISEQ and join NASDAQ ICON has reported a 19% increase in revenue in the third quarter compared to the same time last year of $286m. Business • 01 Nov 12
ICON reports a 19% increase in revenue in Q2 Biotech firm ICON has reported a 19% increase in revenue to $277m in the second quarter of 2012. Business • 24 Jul 12
ICON's Gray to retire from board in July ICON's vice chairman Peter Gray has decided to retire from the board at the company's AGM next month. Business • 12 Jun 12
ICON reports 10% rise in first quarter revenue The biotech company ICON has reported a 10% increase in revenue from $229.3m to $252m in the first quarter of 2012. Business • 24 Apr 12
